Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Hydrocodone and Acetaminophen Tablets Recalled for Product Mix-up

Agency Publication Date: December 7, 2021
Share:
Sign in to monitor this recall

Summary

Ascent Pharmaceuticals, Inc. is recalling approximately 9,744 bottles of Hydrocodone Bitartrate and Acetaminophen (10 mg/325 mg) tablets due to a product mix-up. The tablets, which are used for pain management, were sold in 100-count bottles under the Camber Pharmaceuticals brand name. No incidents or injuries have been reported to date regarding this issue.

Risk

A product mix-up means a bottle may contain the wrong medication or the wrong dosage strength. This could lead to patients receiving unintended medication, resulting in either a lack of pain relief or potential adverse side effects from the incorrect drug.

What You Should Do

  1. This recall affects 100-count bottles of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, manufactured for Camber Pharmaceuticals, Inc. (NDC 31722-997-01).
  2. Check your prescription bottle label for lot number 21070817 with an expiration date of June 2023 (Exp 6/2023).
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg (100-count bottle)by Camber Pharmaceuticals
Variants: 10 mg/325 mg, Tablet, Rx only
Lot Numbers:
21070817 (Exp 6/2023)
NDC:
31722-997-01

Manufactured for Camber Pharmaceuticals, Inc. by Ascent Pharmaceuticals, Inc.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 89060
Status: Resolved
Manufacturer: Ascent Pharmaceuticals, Inc.
Sold By: Camber Pharmaceuticals, Inc.
Manufactured In: United States
Units Affected: 9744 bottles
Distributed To: Nationwide
Agency Last Updated: December 17, 2021

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.